NDC 71335-1071 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-1071

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1071-03 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-0)May 2, 2022
71335-1071-130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-1)Feb 11, 2019
71335-1071-210 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-2)Feb 22, 2019
71335-1071-35 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-3)Jan 25, 2019
71335-1071-44 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-4)Oct 28, 2021
71335-1071-56 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-5)Aug 16, 2021
71335-1071-614 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-6)May 2, 2022
71335-1071-760 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-7)May 2, 2022
71335-1071-812 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-8)May 2, 2022
71335-1071-990 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-1071-9)May 2, 2022

Other Ondansetron products